A2 Biotherapeutics Inc.
Clinical trials sponsored by A2 Biotherapeutics Inc., explained in plain language.
-
Smart immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors, including colorectal, pancreatic, lung, ovarian, and mesothelioma cancers. The therapy uses a patient's own immune cells, modified to target cancer cells while sparing healthy ones. The goal …
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Scientists gather key materials to create personalized cell therapies for Hard-to-Treat cancers
Knowledge-focused Recruiting nowThis study collects tumor tissue and blood cells from 200 adults with advanced solid tumors like colorectal, lung, or pancreatic cancer. Researchers will analyze the tumors for genetic changes and store participants' own T cells for possible future use in making a personalized CA…
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC